Pfizer vows to fight Lipitor copies in Canada

Generic forms of Pfizer's (NYSE: PFE) blockbuster Lipitor cholesterol fighter began flooding into Canada on Wednesday, in a taste of what is to come for the $12 billion-a-year drug next year in the U.S. Report